Assessing the impact of HBV NAT on window period reduction and residual risk

被引：86
作者：
Kleinman, Steven H.
Busch, Michael P.
机构：
[1] Blood Syst Res Inst, San Francisco, CA 94118 USA
[2] Kleinman BioMed Consulting, Victoria, BC, Canada
[3] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada
[4] Blood Syst Inc, Scottsdale, AZ USA
[5] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL VIROLOGY | 2006年 / 36卷
关键词：
hepatitis B virus (HBV); blood donation; blood transfusion; nucleic acid amplification testing (NAT);
D O I：
10.1016/S1386-6532(06)80005-3
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：S23 / S29
页数：7
相关论文
共 31 条
[1]   Estimated risk of transfusion-transmitted viral infections in Spain [J].
Alvarez, M ;
Oyonarte, S ;
Rodríguez, PM ;
Hernández, JM .
TRANSFUSION, 2002, 42 (08) :994-998
[2]   Comparative sensitivity of HBVNATs and HBsAg assays for detection of acute HBV infection [J].
Biswas, R ;
Tabor, E ;
Hsia, CC ;
Wright, DJ ;
Laycock, ME ;
Fiebig, EW ;
Peddada, L ;
Smith, R ;
Schreiber, GB ;
Epstein, JS ;
Nemo, GJ ;
Busch, MP .
TRANSFUSION, 2003, 43 (06) :788-798
[3]   A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors [J].
Busch, MP ;
Glynn, SA ;
Stramer, SL ;
Strong, DM ;
Caglioti, S ;
Wright, DJ ;
Pappalardo, B ;
Kleinman, SH .
TRANSFUSION, 2005, 45 (02) :254-264
[4]   Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? [J].
Busch, MP .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2004, 11 (01) :26-32
[5]  
Caglioti S, 2004, TRANSFUSION, V44, p84A
[6]  
Coste J, 2005, VOX SANG, V88, P289, DOI 10.1111/j.1423-0410.2005.00636_1.x
[7]   Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population [J].
Dodd, RY ;
Notari, EP ;
Stramer, SL .
TRANSFUSION, 2002, 42 (08) :975-979
[8]   International application of the incidence rate/window period model [J].
Glynn, SA ;
Kleinman, SH ;
Wright, DJ ;
Busch, MP .
TRANSFUSION, 2002, 42 (08) :966-972
[9]  
Kleimenova NG, 1996, GEOMAGN AERON+, V36, P52
[10]   The incidence window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection [J].
Kleinman, S ;
Busch, MP ;
Korelitz, JJ ;
Schreiber, GB .
TRANSFUSION MEDICINE REVIEWS, 1997, 11 (03) :155-172
1234